Advertisement

Head and Neck Pathology

, Volume 11, Issue 1, pp 16–22 | Cite as

Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx

  • Edward B. Stelow
  • Bruce M. Wenig
Original Paper
Part of the following topical collections:
  1. World Health Organization Classification Update

Abstract

The current WHO classification system for tumors of the head and neck has made few changes from the previous edition with regards to tumors of the nasopharynx. The classification system is discussed here with particular attention to nasopharyngeal carcinoma, nasopharyngeal papillary adenocarcinoma, salivary gland anlage tumor, hairy polyp, juvenile angiofibroma, and other tumors.

Keywords

Nasopharynx Carcinoma Squamous cell carcinoma Papillary Adenocarcinoma Angiofibroma Salivary gland Anlage Angiofibroma WHO 

Notes

Compliance with Ethical Standards

Conflict of interest

Drs. Wenig and Stelow have no conflict of interest.

Human and Animal Participants

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    Petersson F. Nasopharyngeal carcinoma: A review. Semin Diagn Pathol. 2015;32:54–73.CrossRefPubMedGoogle Scholar
  2. 2.
    Niedobitek G, Hansmann ML, Herbst H, Young LS, Dienemann D, Hartmann CA, Finn T, Pitteroff S, Welt A, Anagnostopoulos I, Friedrich R, Lobeck H, Sam CK, Araujo I, Rickinson AB, Stein H. Epstein–Barr-Virus and Carcinomas—undifferentiated carcinomas but not squamous-cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol. 1991;165:17–24.CrossRefPubMedGoogle Scholar
  3. 3.
    Goldsmith DB, West TM, Morton R. HLA associations with nasopharyngeal carcinoma in southern Chinese: a meta-analysis. Clin Otolaryngol. 2002;27:61–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Chan SH, Chew CT, Prasad U, Wee GB, Srinivasan N, Kunaratnam N. Hla and nasopharyngeal carcinoma in Malays. Brit J Cancer. 1985;51:389–92.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Hildesheim A, Chen CJ, Caporaso NE, Cheng YJ, Hoover RN, Hsu MM, Levine PH, Chen IH, Chen JY, Yang CS, Daly AK, Idle JR. Cytochrome P4502e1 genetic polymorphisms and risk of nasopharyngeal carcinoma—results from a case-control study conducted in Taiwan. Cancer Epidemiol Biomar. 1995;4:607–10.Google Scholar
  6. 6.
    Zou XN, Lu SH, Liu B. Volatile N-nitrosamines and their precursors in Chinese salted fish—a possible etiologic factor for NPC in China. Int J Cancer. 1994;59:155–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Ji XM, Zhang WD, Xie CH, Wang BC, Zhang G, Zhou FX. Nasopharyngeal carcinoma risk by histologic type in central China: impact of smoking, alcohol and family history. Int J Cancer. 2011;129:724–32.CrossRefPubMedGoogle Scholar
  8. 8.
    Reddy SP, Raslan WF, Gooneratne S, Kathuria S, Marks JE. Prognostic-significance of keratinization in nasopharyngeal carcinoma. Am J Otolaryngol. 1995;16:103–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Shanmugaratnam K, Chan SH, Dethe G, Goh JEH, Khor TH, Simons MJ, Tye CY. Histo-pathology of nasopharyngeal carcinoma—correlations with epidemiology, survival rates and other biological characteristics. Cancer 1979;44:1029–44.CrossRefPubMedGoogle Scholar
  10. 10.
    Sun XM, Su SF, Chen CY, Han F, Zhao C, Xiao WW, Deng XW, Huang SM, Lin CG, Lu TX. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110:398–403.CrossRefPubMedGoogle Scholar
  11. 11.
    Robinson M, Suh YE, Paleri V, Devlin D, Ayaz B, Pertl L, Thavaraj S. Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population. Infect Agents Cancer 2013;8:30.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Wenig BM, Hyams VJ, Heffner DK. Nasopharyngeal papillary adenocarcinoma. a clinicopathologic study of a low-grade carcinoma. Am J Surg Pathol. 1988;12:946–53.CrossRefPubMedGoogle Scholar
  13. 13.
    Pineda-Daboin K, Neto A, Ochoa-Perez V, Luna MA. Nasopharyngeal adenocarcinomas: a clinicopathologic study of 44 cases including immunohistochemical features of 18 papillary phenotypes. Ann Diagn Pathol. 2006;10:215–21.CrossRefPubMedGoogle Scholar
  14. 14.
    Dehner LP, Valbuena L, Perezatayde A, Reddick RL, Askin FB, Rosai J. Salivary-gland anlage tumor (congenital pleomorphic adenoma)—a clinicopathological, immunohistochemical and ultrastructural-study of 9 cases. Am J Surg Pathol. 1994;18:25–36.CrossRefPubMedGoogle Scholar
  15. 15.
    Herrmann BW, Dehner LP, Lieu JEC. Congenital salivary gland anlage tumor: a case series and review of the literature. Int J Pediatr Otorhinolaryngol. 2005;69:149–56.CrossRefPubMedGoogle Scholar
  16. 16.
    Heffner DK, Thompson LD, Schall DG, Anderson V. Pharyngeal dermoids (“hairy polyps”) as accessory auricles. Ann Otol Rhinol Laryngol. 1996;105:819–24.CrossRefPubMedGoogle Scholar
  17. 17.
    Luk IS, Chan JK, Chow SM, Leung S. Pituitary adenoma presenting as sinonasal tumor: pitfalls in diagnosis. Hum Pathol. 1996;27:605–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Byrne MN, Sessions DG. Nasopharyngeal craniopharyngioma. Case report and literature review. Ann Otol Rhinol Laryngol. 1990;99:633–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Apostol JV, Frazell EL. Juvenile nasopharyngeal angiofibroma. A clinical study. Cancer. 1965;18:869–78.CrossRefPubMedGoogle Scholar
  20. 20.
    Hubbard EM. Nasopharyngeal angiofibromas. AMA Arch Pathol. 1958;65:192–204.PubMedGoogle Scholar
  21. 21.
    Neel HB III, Whicker JH, Devine KD, Weiland LH. Juvenile angiofibroma. review of 120 cases. Am J Surg. 1973;126:547–56.CrossRefPubMedGoogle Scholar
  22. 22.
    Sternberg SS. Pathology of juvenile nasopharyngeal angiofibroma; a lesion of adolescent males. Cancer. 1954;7:15–28.CrossRefPubMedGoogle Scholar
  23. 23.
    Giardiello FM, Hamilton SR, Krush AJ, Offerhaus JA, Booker SV, Petersen GM. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology. 1993;105:1550–2.CrossRefPubMedGoogle Scholar
  24. 24.
    Guertl B, Beham A, Zechner R, Stammberger H, Hoefler G. Nasopharyngeal angiofibroma: an APC-gene-associated tumor? Hum Pathol. 2000;31:1411–3.CrossRefPubMedGoogle Scholar
  25. 25.
    Chen KT, Bauer FW. Sarcomatous transformation of nasopharyngeal angiofibroma. Cancer. 1982;49:369–71.CrossRefPubMedGoogle Scholar
  26. 26.
    Spagnolo DV, Papadimitriou JM, Archer M. Postirradiation malignant fibrous histiocytoma arising in juvenile nasopharyngeal angiofibroma and producing alpha-1-antitrypsin. Histopathology. 1984;8:339–52.CrossRefPubMedGoogle Scholar
  27. 27.
    Beham A, Fletcher CD, Kainz J, Schmid C, Humer U. Nasopharyngeal angiofibroma: an immunohistochemical study of 32 cases. Virchows Arch A Pathol Anat Histopathol. 1993;423:281–5.CrossRefPubMedGoogle Scholar
  28. 28.
    Hwang HC, Mills SE, Patterson K, Gown AM. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol. 1998;11:1122–6.PubMedGoogle Scholar
  29. 29.
    Abraham SC, Montgomery EA, Giardiello FM, Wu TT. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol. 2001;158:1073–8.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Dahlin DC, Maccarty CS. Chordoma. Cancer. 1952;5:1170–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW. Chordomas and cartilaginous tumors at the skull base. Cancer. 1973;32:410–20.CrossRefPubMedGoogle Scholar
  32. 32.
    Hoch BL, Nielsen GP, Liebsch NJ, Rosenberg AE. Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases. Am J Surg Pathol. 2006;30:811–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Mitchell A, Scheithauer BW, Unni KK, Forsyth PJ, Wold LE, McGivney DJ. Chordoma and chondroid neoplasms of the spheno-occiput. An immunohistochemical study of 41 cases with prognostic and nosologic implications. Cancer. 1993;72:2943–9.CrossRefPubMedGoogle Scholar
  34. 34.
    O’Connell JX, Renard LG, Liebsch NJ, Efird JT, Munzenrider JE, Rosenberg AE. Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases. Cancer. 1994;74:2261–7.CrossRefPubMedGoogle Scholar
  35. 35.
    Perzin KH, Pushparaj N. Nonepithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx. A clinicopathologic study. XIV: Chordomas. Cancer. 1986;57:784–96.CrossRefPubMedGoogle Scholar
  36. 36.
    Meis JM, Raymond AK, Evans HL, Charles RE, Giraldo AA. “Dedifferentiated” chordoma. A clinicopathologic and immunohistochemical study of three cases. Am J Surg Pathol. 1987;11:516–25.CrossRefPubMedGoogle Scholar
  37. 37.
    Mendenhall WM, Mendenhall CM, Lewis SB, Villaret DB, Mendenhall NP. Skull base chordoma. Head Neck. 2005;27:159–65.CrossRefPubMedGoogle Scholar
  38. 38.
    Wojno KJ, Hruban RH, Garin-Chesa P, Huvos AG. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases. Am J Surg Pathol. 1992;16:1144–52.CrossRefPubMedGoogle Scholar
  39. 39.
    Sangoi AR, Karamchandani J, Lane B, Higgins JP, Rouse RV, Brooks JD, McKenney JK. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases. Mod Pathol. 2011;24:425–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Hanna E, Wanamaker J, Adelstein D, Tubbs R, Lavertu P. Extranodal lymphomas of the head and neck—a 20-year experience. Arch Otolaryngol. 1997;123:1318–23.CrossRefGoogle Scholar
  41. 41.
    Jaffe ES. Lymphoid lesions of the head and neck: A model of lymphocyte homing and lymphomagenesis. Modern Pathol. 2002;15:255–63.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Anatomic PathologyUniversity of Virginia Health SystemCharlottesvilleUSA
  2. 2.H. Lee Moffitt Cancer Center and Research InstituteTampaUSA

Personalised recommendations